MX2009004682A - Uso de dmae para el tratamiento de deficit cognitivo ligero. - Google Patents

Uso de dmae para el tratamiento de deficit cognitivo ligero.

Info

Publication number
MX2009004682A
MX2009004682A MX2009004682A MX2009004682A MX2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A
Authority
MX
Mexico
Prior art keywords
dmae
treatment
cognitive impairment
mild cognitive
sole agent
Prior art date
Application number
MX2009004682A
Other languages
English (en)
Spanish (es)
Inventor
Pierre Fabre
Christophe Przybylski
Bruno Dubois
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MX2009004682A publication Critical patent/MX2009004682A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2009004682A 2006-10-31 2007-10-31 Uso de dmae para el tratamiento de deficit cognitivo ligero. MX2009004682A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0609548A FR2907679B1 (fr) 2006-10-31 2006-10-31 Utilisation de dmae pour le traitement de deficit cognitif leger
PCT/EP2007/061737 WO2008053011A1 (fr) 2006-10-31 2007-10-31 Le dmae en tant qu'agent unique pour le traitement de deficit cognitif leger

Publications (1)

Publication Number Publication Date
MX2009004682A true MX2009004682A (es) 2009-09-28

Family

ID=38050144

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004682A MX2009004682A (es) 2006-10-31 2007-10-31 Uso de dmae para el tratamiento de deficit cognitivo ligero.

Country Status (18)

Country Link
US (1) US8207218B2 (https=)
EP (1) EP2083814B1 (https=)
JP (1) JP2010508253A (https=)
KR (1) KR20090082428A (https=)
CN (1) CN101528220A (https=)
AR (1) AR063764A1 (https=)
AU (1) AU2007316137A1 (https=)
BR (1) BRPI0718263A2 (https=)
CA (1) CA2667983A1 (https=)
FR (1) FR2907679B1 (https=)
IL (1) IL198463A0 (https=)
MA (1) MA30925B1 (https=)
MX (1) MX2009004682A (https=)
NO (1) NO20092099L (https=)
RU (1) RU2009120137A (https=)
TN (1) TN2009000159A1 (https=)
WO (1) WO2008053011A1 (https=)
ZA (1) ZA200903626B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150157046A1 (en) * 2013-12-10 2015-06-11 Lifewave, Inc. Nutritional product composition for the mind

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002320251A1 (en) * 2001-07-05 2003-01-21 Vital Basics, Inc. Compositions for improving mental performance
US20060211721A1 (en) * 2005-03-21 2006-09-21 Roberts Alan R Nutraceutical formulation of a cognitive enhancement system

Also Published As

Publication number Publication date
IL198463A0 (en) 2010-02-17
US20090298908A1 (en) 2009-12-03
BRPI0718263A2 (pt) 2014-01-07
CN101528220A (zh) 2009-09-09
FR2907679A1 (fr) 2008-05-02
MA30925B1 (fr) 2009-11-02
CA2667983A1 (fr) 2008-05-08
TN2009000159A1 (fr) 2010-10-18
AU2007316137A1 (en) 2008-05-08
US8207218B2 (en) 2012-06-26
AR063764A1 (es) 2009-02-18
FR2907679B1 (fr) 2009-10-30
WO2008053011A1 (fr) 2008-05-08
KR20090082428A (ko) 2009-07-30
RU2009120137A (ru) 2010-12-10
NO20092099L (no) 2009-07-17
EP2083814A1 (fr) 2009-08-05
JP2010508253A (ja) 2010-03-18
ZA200903626B (en) 2010-07-28
EP2083814B1 (fr) 2013-03-20

Similar Documents

Publication Publication Date Title
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
UA95975C2 (ru) N-метиламинометилизоиндольные соединения, композиции, содержащие их, и способы их применения
UA91560C2 (ru) Соединения ряда изоиндолимидов, их композиция и применение
UA97795C2 (uk) Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки
MX2011012122A (es) Derivados de tiofeno.
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
MX2009001062A (es) Agonistas de ep2.
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
IL193252A0 (en) N-hydroxyacrylamide compounds
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
MX2009013501A (es) Compuestos piperidinicos y sus usos.
WO2009032843A3 (en) Deuterated ethambutols and their use
TW200639156A (en) New compounds
GB2446341A (en) Method and system for transdermal drug delivery
TW200734334A (en) Treatment of substance abuse
WO2011153458A3 (en) Compositions and methods for inhibition of or treatment of dengue virus infection
WO2008004100A9 (en) Therapeutic compounds
WO2007121471A3 (en) Dialkyl ether delivery agents
TW200719903A (en) Compositions for the treatment of neoplasms
MX2009004682A (es) Uso de dmae para el tratamiento de deficit cognitivo ligero.
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
MY160963A (en) Sustained-release therapeutic agent for hypertension and renal dysfunction
AU2016219606A1 (en) Pharmaceutical composition for treating or preventing burn injuries

Legal Events

Date Code Title Description
FA Abandonment or withdrawal